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Abstract Gap junction (GJ) intercellular communication (GJIC) is vital to ensure proper cell and tissue function. GJ
are multimeric structures composed of proteins called connexins. Modifications on stability or subcellular distribution of
connexins have a direct impact on the extent of GJIC. In this study we have investigated the role of the proteasome in
regulation of connexin 43 (Cx43) internalization. Although the participation of both the proteasome and lysosome has
long been suggested in Cx43 degradation, the molecular mechanisms whereby proteasome contributes to regulate Cx43
internalization and intercellular communication are still unclear. The results presented in this study envision a new
mechanism whereby proteasome regulates GJIC by modulating interaction between Cx43 and ZO-1. Immunoprecipita-
tion experiments, in the presence of proteasome inhibitors, together with immunofluorescence data indicate that the
proteasome regulates interaction between Cx43 and ZO-1. Overexpression of the PDZ2 domain of ZO-1 and the
expression of Cx-43 fused in frame with a V5/HIS tag, suggest that interaction between the two proteins occurs through
the PDZ2 domain of ZO-1 and the C-terminus of Cx43. When interaction between Cx43 and ZO-1 is reduced, as in the
presence of proteasome inhibitors, Cx43 accumulates, forming large GJ plaques at plasma membrane. Data presented
in this article suggest a new pathway whereby alterations in proteasome activity may impact on GJIC as well as on
non-junctional communication with extracellular environment, contributing to cell and tissue dysfunction. J. Cell.
Biochem. 102: 719–728, 2007.  2007 Wiley-Liss, Inc.
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Gap junctions (GJ) are intercellular channels
that permit the passage of small molecules such
as metabolites, ions, and second messengers
[Kumar and Gilula, 1996]. Exchange of low
molecular weight substances through gap junc-
tions is an important mechanism for cells to
regulate homeostasis, proliferation, differentia-
tion and to ensure homogeneous tissue function
[Simon and Goodenough, 1998; Matemba et al.,
2006]. Gap junctions consist of two hemichan-
nels, called connexons, that are located in the
plasma membrane of two adjacent cells. Each
connexon is composed of six subunits of a
protein called connexin (Cx).
The extent of gap junction intercellular
communication is a direct result of the number
and functionality of these connexin-based
pores. In addition to regulation by transcrip-
tional control, other rapid mechanisms are
also involved in regulation of gap junction
intercellular communication. These mechan-
isms include altered subcellular localization
and a variety of post-transcriptional modifica-
tions such as phosphorylation and rapid degra-
dation of connexins. Both the proteasome
[Laing and Beyer, 1995; Beardslee et al., 2000;
Musil et al., 2000; Girao and Pereira, 2003;
Fernandes et al., 2004 Laing et al., 2005] and
lysosome [Laing et al., 1997; Musil et al., 2000]
have been implicated in degradation of Cx43.
Whereas degradation of Cx43 by the lysosome
has long been established, the role of the
proteasome in Cx43 turnover is still poorly
understood. Initial studies suggested that the
proteasome could be directly involved in con-
nexin degradation [Laing and Beyer, 1995].
However, more recently, it has been hypothe-
sized that proteasome acts by regulating the
stability of Cx43 at the plasma membrane,
most likely by degrading a connexin-interacting
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protein [Musil et al., 2000; Girao and Pereira,
2003]. Indeed, it has been demonstrated that
proteasome inhibition is associated with an
increase in gap junctional plaque assembly
and intercellular dye transfer, suggesting that
this proteolytic complex is somehow involved in
internalization of Cx43.
Cx43 is known to interact with several
proteins, including cytoskeletal proteins and
anchoring proteins, such as E-cadherin [Fuji-
moto et al., 1997], caveolin-1 [Schubert et al.,
2002], and ZO-1 [Giepmans and Moolenaar,
1998; Toyofuku et al., 1998;Wuet al., 2003] that
may regulate channel assembly and/or the
stability of Cx43 at the plasma membrane. The
interaction of Cx43 with zonula occludens (ZO-
1) has been studied in great detail and several
studies have focused on the mechanisms and
functional implications of such interaction. ZO-
1 is a member of the membrane-associated
guanylate kinase (MAGUK) family, that is,
important in regulation of signal transduction,
protein targeting and control of cell polarity
[Gonzalez-Mariscal et al., 2000; Harhaj and
Antonetti, 2004]. Immunoprecipitation and
yeast-two-hybrid experiments have demon-
strated that interaction between ZO-1 and
Cx43 occurs through the last five aminoacids
(DDLEI) of theC-terminus (CT) of Cx43 and the
second PDZ domain (PDZ2) of ZO-1 [Giepmans
and Moolenaar, 1998; Giepmans et al., 2001;
Singh and Lampe, 2003; Jin et al., 2004; Sorgen
et al., 2004]. Moreover, studies using mutant
connexin peptides that lack the CT binding
domain or in which the CT is blocked, revealed
that formation of GJ can occur without interac-
tion of Cx43 with ZO-1 [Jordan et al., 1999;
Bukauskas et al., 2000; Toyofuku et al., 2001b].
However, the GJ formed under such conditions
are abnormally large and some of the channels
are inactive, suggesting that ZO-1 is somehow
involved in regulation of GJ function [Hunter et
al., 2003; 2005; Jin et al., 2004]. The implica-
tions and the physiological role of the interac-
tion between Cx43 and ZO-1 remain
controversial. Early studies hypothesized that
ZO-1 could act as an anchor stabilizing GJ at
plasma membrane, most likely through cytos-
keletal anchoring [Toyofuku et al., 1998,
2001b]. More recently, it was demonstrated
that interaction between Cx43 and ZO-1 is a
dynamic process that is involved in the regula-
tion of Cx43 endocytosis [Barker et al., 2002;
Duffy et al., 2004; Segretain et al., 2004].
However, the precise role of ZO-1 in Cx43
endocytosis is still controversial. Indeed, stu-
dies carried out in Sertoli cells and cardiac
myocytes showed that Cx43 interacts more
strongly with ZO-1 during endocytosis of GJ
[Barker et al., 2002; Segretain et al., 2004].
Conversely, data obtained by Duffy suggested
that internalization of GJs, induced by intra-
cellular acidification, is facilitated by dissocia-
tion of Cx43 from ZO-1 [Duffy et al., 2004].
More recently it was demonstrated that
interaction between Cx43 and ZO-1 might act
as a regulator of the size ofGJ, by controlling the
rate of channel accretion at plaque periphery
[Hunter et al., 2005]. Indeed, when interaction
between Cx43 and ZO-1 is reduced, such as by
the attachment of a tag to the C-terminus of
Cx43 or by the use of a peptide inhibitor that
contains theCx43PDZ-binding domain, there is
a reduction of ZO-1 peripherally associatedwith
GJ and a significant increase in plaque size.
However, the regulation of the interaction
between ZO-1 and Cx43 still remains to be
elucidated. In this study we provide evidence
that the proteasome plays an important role in
regulating interaction between Cx43 and ZO-1.
Indeed, the data presented in this study show
that proteasome inhibition results in a decreas-
ed interaction between Cx43 and ZO-1. More-
over, the presence of a tag in the C-terminus of
Cx43, that prevents interaction with ZO-1,
reverts the MG132-induced accumulation of
large Cx-43 plaques at the plasma membrane.
These data suggest that efficient interaction
between Cx43 and ZO-1 is regulated by the
proteasome, presumably by involving degrada-
tion of a putative Cx43 binding protein.
MATERIALS AND METHODS
Antibodies
The rabbit anti-Cx43 polyclonal antibody,
obtained from Zymed was raised against a
peptide corresponding to a segment of the third
cytoplasmic domain (C-terminal portion) of rat
Cx43 (Cat No 71-0700). The mouse anti-Cx43
monoclonal antibody obtained from Zymed
was raised against a cytoplasmic sequence
located near the C-terminus of rat Cx43 (Cat
No 13-8300). The mouse anti-Cx43 monoclonal
antibody obtained from BD Tranduction Labo-
ratories was raised against a peptide sequence
that represents amino acid residues 252–270 of
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rat Cx43. Polyclonal antibodies against ZO-1
were obtained from Zymed.
Culture and Treatment of Cells
NRK cells or HEK293 cells were cultured in
Dulbecco’s Modified of Eagle’sMedium (DMEM)
supplemented with 10% fetal bovine serum and
penicillin/streptomycin. To determine the role
of the proteasome on Cx43 interaction with
ZO-1, cells were incubated, for 2 h, in the
presence of the proteasome inhibitors MG132
(40 mM) or Lactacystin (10 mM).
Cell Transfection
Transient transfections of HEK 293 cells were
performed by incubating the cells with Lipofect-
AMINE reagent in low serum medium (Life
Technologies), during6h.Plasmidsencoding full
length Cx43 orHIS-V5-tagged Cx43were cloned
into the pcDNA3.1/V5/His vector (Invitrogene).
Immunoprecipitation and Western Blotting
NRK cells or HEK293 transfected cells were
rinsed with PBS at 48C, ressuspended in lysis
buffer (190 mM NaCl, 50 mM Tris-HCl, 6 mM
EDTA, 1% Triton X-100, pH 8.3) supplemented
with protease inhibitor cocktail (Roche), 2 mM
PMSF,10mMiodacetamide, 50mMNaF,500mM
NaVO4, and incubated on ice during 30min.The
samples were then centrifuged at 10,000g,
during 10 min, and the supernatants used for
immunoprecipitation. Briefly, protein A was
incubated with polyclonal antibodies directed
against Cx43 (Zymed, Cat No 71-0700), for 1 h,
at 48C or nonimmune rabbit serum, followed by
incubation with supernatants, for 3 h at 48C.
The samples were then centrifuged and the
protein A-sepharose sediments ressuspended
in Laemmli buffer and denatured at 378C, for
30 min.
For Western blot analysis of the immunopre-
cipitated proteins, samples were separated by
SDS–PAGE, transferred to aPVDFmembrane,
and labeled withmonoclonal antibodies to Cx43
(Zymed, Cat No 13-8300) or polyclonal anti-
bodies to ZO-1.
Immunofluorescence
Cells grown on glass coverslips were fixed
with 4% paraformaldehyde in phosphate buf-
fered saline PBS. The samples were then
washed with PBS, permeabilised with 0.2% v/v
Triton X-100 in PBS, and blocked with goat
serum (1:10) for 20 min prior to incubation with
primary antibodies. Incubation with primary
antibodies against Cx43 (Transduction Lab)
and ZO-1 (Zymed) proceeded for 1 h at room
temperature. The samples were then washed
three timeswithPBSbefore incubationwith the
secondary antibody for 1hat room temperature.
The specimenswere rinsed inPBSandmounted
with Glycergel (Dako). All solutions were made
up in 0.2% w/v BSA (Sigma) containing 0.02%
sodium azide (Sigma) in PBS. For controls,
primary antibodies were omitted. The images
were collected by confocal microscopy using
a Carl Zeiss LSM410 system and Bio-Rad
MRC-600.
RESULTS
Previous studies showed that inhibition of
Cx43-ZO-1 interaction results in a significant
increase in the size of GJ plaques [Hunter et al.,
2003; 2005; Jin et al., 2004]. On the other hand,
it was shown that proteasome inhibition leads
to the accumulation of Cx43 at the plasma
membrane, with the formation of large plaques
[Musil et al., 2000; Girao and Pereira, 2003;
Fernandes et al., 2004]. This led us to hypothe-
size that an active proteasome is required to
regulate the interaction of Cx43 with ZO-1.
To investigate the role of the proteasome in
Cx43-ZO-1 interaction, NRK cells, that endo-
genously express Cx43 and ZO-1, were incu-
bated either in the presence or absence of the
proteasome inhibitor MG132 (or lactacystin),
for 2 h. To further evaluate the association of
Cx43 and ZO-1, Cx43 or ZO-1 was selectively
immunoprecipitated using polyclonal antibo-
dies against each of these proteins, followed by
Western blot and probing with antibodies
Fig. 1. Proteasome inhibitors reduce the interaction between
Cx43 and ZO-1. Endogenous Cx43 from NRK cells was
immunoprecipitated using polyclonal antibodies against ZO-1
(A) or Cx43 (B). Immunoprecipitated material was resolved by
SDS–PAGEand immunoblottedwith antibodies againstCx43 (A)
or ZO-1 and E-cadherin (B).
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against ZO-1 or Cx43, respectively (Fig. 1). The
results obtained clearly show that, in the cells
incubated with MG132 (or lactacystin), the
amount of Cx43 immunoprecipitated with
anti-ZO-1 antibodies (Fig. 1A), and the amount
of ZO-1 immunoprecipitated with anti-Cx43
antibodies (Fig. 1B), is lower than in control
cells. These results demonstrate, for the first
time, that proteasome inhibition leads to a
decreased interaction between Cx43 and ZO-1.
To further investigate if the effect of protea-
some inhibitors in binding of Cx43 to ZO-1 is
specific, cell lyzates were immunoprecipitat-
ed with anti-Cx43 antibodies and were sub-
sequently Western blotted with antibodies
against E-cadherin, which is known to interact
with Cx43. The results presented in Figure 1B
show that interaction between Cx43 and
E-cadherin is not affected by proteasome inhi-
bitors. This suggests that it is not likely that
proteasome inhibitors are unspecifically dis-
rupting interaction between Cx43 and its bind-
ing partners. To verify that the effect of MG132
on the amount of immunoprecipitated proteins
is not due to variations in the initial amount
of proteins, we reprobed the same membranes
with the antibodies used in the immunoprecipi-
tation assays. The results show that the amount
of Cx43 and ZO-1 are not significantly altered
following incubation withMG132. In the immu-
noprecipitatedCx43 there is an accumulation of
slower migrating bands that correspond to the
phosphorylated forms of the protein (Fig. 1B,
middle panel). Additional controls were gener-
ated by probing the membranes, containing
extracts before immunoprecipitation with Pon-
ceau S or with antibodies against actin. In both
cases the staining for the different samples was
comparable, indicating equal sample loading
(data not shown).
To further confirm the decrease of Cx43-ZO-1
interaction induced by proteasome inhibitors,
NRK cells, that endogenously express Cx43,
were incubated either in the presence or
absence of MG132 (or lactacystin), and then
fixed and stained with monoclonal antibodies
directed against Cx43 and polyclonal antibodies
against ZO-1. Cells were subsequently imaged
by immunofluorescence confocal microscopy.
The results show that, in controls, the majority
of Cx43 colocalizes with ZO-1 (Fig. 2A a–c) at
the plasma membrane, while in cells incubat-
edwithMG132 it is possible to observe the form-
ation of large punctate staining (Fig. 2A d–f;
see arrows) corresponding toGJ plaques that do
not colocalize with ZO-1 (Fig. 2A f; see arrows).
To confirm that this does not result from the
fixation procedure, in addition to PFA, cells
were also fixedwithmethanol/acetone (Fig. 2B).
Taken together, these results suggest that
efficient interaction between Cx43 and ZO-1
requires an active proteasome. Based on this
observation and previous reports it is possible to
speculate that proteasome inhibitors may pre-
vent degradation of a putative Cx43 interacting
protein, thus preventing an efficient association
between Cx43 and ZO-1.
To confirm that the binding of a protein to the
C-terminus of Cx43 is sufficient to disrupt or
weaken its interaction with ZO-1, we added a
tag to the C-terminus of Cx43. HEK239 cells,
that do not endogenously express Cx43
[Toyofuku et al., 1998, 2001a,b], were transi-
ently transfected with a plasmid containing the
cDNA for the full length of Cx43with orwithout
a V5/His tag at the C-terminus. Cx43 was
subsequently immunoprecipitated and the
amount of ZO-1 that co-precipitated was
assessed byWestern blot. The results presented
in Figure 3 show that the amount of ZO-1 that
co-precipitates with Cx43 significantly decreas-
es when a tag is added to the C-terminus
of Cx43. The observation that a tag in the
C-terminus of Cx43 reduces but not completely
abolishes the interaction with ZO-1, can reflect
either the residual expression of connexinswith
a PDZ binding motif in HEK293 cells or that a
week interaction with ZO-1 still occurs in the
absence of a PDZ binding domain in Cx43.
To confirm that the levels of expression of
both forms (tagged or untagged) of Cx43 were
similar, the membranes were reprobed with
antibodies to Cx43.
To further confirm that interaction of Cx43
with ZO-1 occurs through the PDZ2 domain of
ZO-1, HEK293 cells were co-transfected with
the untagged form of Cx43 and the PDZ2
domain of ZO-1. The PDZ2 domain of ZO-1 is
the portion of the protein that interactswith the
last 5 aminoacids of the C-terminus of Cx43.
Thus, overexpression of the PDZ2 domain is
likely to act as a competitive inhibitor for the
binding of ZO-1 to the C-terminus of Cx43. As
shown in Figure 4A the amount of ZO-1 that
coprecipitates with Cx43 is lower in cells that
overexpress the PDZ2 domain as compared to
controls. These results were further confirmed
by immunofluorescence. Indeed, overexpres-
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sion of the PDZ2 domain results in a decreased
co-localization between Cx43 and endogenous
ZO-1 (Fig. 4B c, f; see arrows). These results
show that overexpression of the PDZ2 domain
of ZO-1 disrupts the interaction between Cx43
and ZO-1.
We do propose a model in which stabilization
of Cx43, at the plasma membrane, depends on
Fig. 2. Proteasome inhibitors reduce the colocalization of Cx43with ZO-1.NRKcells were incubatedwith
20 mMMG132, for 2 h, and then fixed either with PFA 4% (A) or methanol/acetone (B) and double labeled
with monoclonal antibodies directed against Cx43 (red) and polyclonal antibodies directed against ZO-1
(green) and imaged by confocalmicroscopy. IncubationwithMG132 results in the accumulation of Cx43 at
theplasmamembraneand in adecrease in the extent of colocalizationbetweenCx43andZO-1 (see arrows).
[Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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the interaction of its C-terminus with the PDZ
domain of ZO-1. We hypothesize that one
mechanism bywhich the Cx43/ZO-1 interaction
is regulated could be by degradation of an as yet
unknown putative protein that binds to the
C-terminus of Cx43. If this were the case, then
binding of a tag to the C-terminus of Cx43
would, make the tagged Cx43 insensitive to the
effects of proteasome inhibitors.
To verify this hypothesis, HEK293 cells were
transfected either with a tagged or untagged
Cx43. The transfected cellswere then incubated
in the presence or absence of the proteasome
inhibitors for 3 h, after which the cells were
fixed and stained with antibodies directed
against Cx43 and ZO-1. As shown in
Figure 5A, when cells overexpressing the
untagged form of Cx43, are incubated with
MG132, a large punctate staining is revealed at
Fig. 3. The presence of a tag in the carboxyl terminal of Cx43
leads to a decreased interaction with ZO-1. HEK293 cells were
transfected with Cx43 or V5-His tagged Cx43. Cx43 was
immunoprecipitated using polyclonal antibodies against Cx43.
Immunoprecipitated material was resolved by SDS–PAGE and
immunoblotted with antibodies against ZO-1 and Cx43 as
indicate in the picture.
Fig. 4. Overexpression of the PDZ2 domain of ZO-1 disrupts
interaction between Cx43 and ZO-1. HEK293 cells were
transfected either with Cx43 alone or cotransfected withCx43
and the PDZ2 domain of ZO-1. Cx43 was immunoprecipitated
using polyclonal antibodies against Cx43. Immunoprecipitated
material was resolved by SDS–PAGE and immunoblotted with
antibodies against ZO-1 (A). Alternatively, the cells were fixed
and double labeledwithmonoclonal antibodies directed against
Cx43 (red) and polyclonal antibodies directed against ZO-1
(green) and imaged by confocal microscopy (B). Overexpression
of the PDZ2 domain of ZO-1 results in a decrease of colo-
calization of Cx43 and ZO-1 (arrows). [Color figure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
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the plasma membrane (Fig. 5A d), as described
before for distribution of endogenousCx43NRK
cells. On the other hand, proteasome inhibition
has no effect on cells that overexpress the
tagged form of Cx43 (Fig. 5B d). Additionally,
cells overexpressing the tagged form of Cx43
present larger punctate staining that do not
colocalize with ZO-1 (Fig. 5B a–c, arrows), as
compared to cells overexpressing the untagged
form of Cx43 (Fig. 5A a–c).
DISCUSSION
The results presented in this study demon-
strate that the proteasome regulates the inter-
action between Cx43 and ZO-1, as revealed by
coprecipitation experiments and immunofluor-
escence analysis. Indeed, incubation of theCx43
expressing NRK cells with the proteasome
inhibitor MG132 (or lactacystin), results both
in a decrease in the amount of ZO-1 that
Fig. 5. The effect of proteasome inhibitors is abolished when Cx43 has a tag in the C-terminus. HEK293
cells transfectedwith untaggedCx43 (A) or V5-His taggedCx43 (B) were incubatedwithMG132, for 3 h. The
cells were then fixed and double labeled with monoclonal antibodies directed against Cx43 (red) and
polyclonal antibodies directed against ZO-1 (green) and imaged by confocal microscopy. Proteasome
inhibition does not result in a decreased colocalization between Cx43 and ZO-1when a tag is present in the
C-terminus of Cx43. [Color figure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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coprecipitates with Cx43 and in a diminished
colocalization of the two proteins at the plasma
membrane. The reduction of Cx43-ZO-1 asso-
ciation is not accompanied by a reduction in
the association between Cx43 and E-cadherin,
suggesting that the proteasome is specifically
affecting the interaction between Cx43 and
ZO-1. Moreover, the presence of a tag in the
C-terminus of Cx43, that prevents interaction
with ZO-1, reverts the MG132-induced accu-
mulation of large Cx43 plaques at the plasma
membrane. Taken together, these findings
suggest that interaction between Cx43 and
ZO-1 can be regulated by the proteasome. We
and others have previously shown that the
proteasome can regulate GJIC [Musil et al.,
2000; Girao and Pereira, 2003; Fernandes et al.,
2004]. Indeed, it is well established that protea-
some inhibition leads to an accumulation of
large plaques of GJ and, as a consequence, to an
increase of GJIC. However, the mechanism
whereby proteasome increases intercellular
communication is still unknown. Recently,
Hunter et al. [2005] proposed a model in which
ZO-1 controls the rate ofCx43 channel accretion
at the periphery of GJ. The authors demon-
strate that reduction of the interaction between
ZO-1 and Cx43 leads to the formation of
abnormally large GJ plaques, with the conco-
mitant accumulation of the phosphorylated
forms of Cx43. This observation is consistent
with the model proposed in the present study.
For example, by preventing degradation of a
putative Cx43-interacting protein, proteasome
inhibitors could also prevent interaction
between Cx43 and ZO-1 resulting in the forma-
tion of large plaques of GJ. Moreover, we have
shown before that phosphorylation acts as a
signal targeting Cx43 for internalization by a
proteasome-dependent mechanism [Girao and
Pereira, 2003; Fernandes et al., 2004]. Indeed, it
is conceivable phosphorylation plays an impor-
tant role in proteasome-dependent regulation
of the interaction between ZO-1 and Cx43.
Consistently, it was hypothesized that interac-
tion between Cx43 and ZO-1 is associated
with increased internalization of Cx43 [Barker
et al., 2002; Segretain et al., 2004] and that
phosphorylation is a prerequisite for suchCx43-
ZO-1 interaction and subsequent Cx43 endo-
cytosis [Barker et al., 2002; Segretain et al.,
2004]. These observations are consistent with
the model proposed in this study for the
proteasome-dependent internalization of Cx43.
That is, proteasome regulates association
between Cx43 and ZO-1 and increased associa-
tionbetweenbothproteins leads internalization
of Cx43 and reduction ofGJIC. According to this
hypothesis, proteasome inhibition would result
in the accumulation of Cx43 at the plasma
membrane. This is likely to be relevant in
conditions where the proteasome activity is
inhibited or reduced, such as under oxidative
stress. Indeed, it was previously shown that
oxidative stress leads to the accumulation of
Cx43 at the plasma membrane and, as a
consequence, to a deregulation of GJIC
[VanSlyke and Musil, 2002, 2005; Girao et al.,
2004]. The results presented in this study
envision an alternative mechanism that may
associate deregulation of intercellular commu-
nication to oxidative stress. It is suggested that
oxidative stress inhibits the proteasome, which,
in turn leads to a poor interaction betweenCx43
andZO-1, thus enhancingGJplaques formation
and intercellular communication. In addition to
its role in GJIC, connexins are also involved in
cell communication with the extracellular
environment via hemichannels. Cx43-based
hemichannels are implicated in various pro-
cesses in cell physiology and pathology includ-
ing volume regulation [Quist et al., 2000], efflux
of NADþ and ATP [Cotrina et al., 1998; Stout
et al., 2002; Goodenough and Paul, 2003] and
acceleration of cell death during metabolic
inhibition [Contreras et al., 2002]. A previous
study indicated that interaction of Cx43 with
ZO-1 could further contribute to regulate the
pool of Cx43 that is involved in GJIC versus the
pool that is involved in the non-junctional
communication mediated by Cx43 hemichan-
nels [Hunter et al., 2005]. Thus, it is conceivable
that the changes in proteasome activity, may
modulate, not onlyGJICbut also non-junctional
communication through connexons, regulating
other cellular processes such as apoptosis.
Taken together, the results presented in this
study suggest a new role for the proteasome in
controlling GJIC, by regulating the association
between Cx43 and ZO-1.
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